Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

885293

registered interest
date	23/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Visual Impairment
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people were registered blind in each of the last five years.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	136158
answer	answer is ministerial correction date of answer 24/04/2018 answer text <p>As NHS Digital collects data on a triennial basis, data can only be provided for two of the last five years.</p><p> </p><p>The number of people who were registered as blind or severely sight impaired in 2013/14 and 2016/17, as well as the number of people who were newly registered in those years is shown in the table below.</p><p> </p><table><tbody><tr><td><p>Year</p></td><td><p>Number of people registered blind or severely sight impaired*</p></td><td><p>Number of new registrations*</p></td></tr><tr><td><p>2013/14</p></td><td><p>143,385</p></td><td><p>8,875</p></td></tr><tr><td><p>2016/17</p></td><td><p>141,525</p></td><td><p>8,605</p></td></tr></tbody></table><p>Source: NHS Digital - The Registered Blind and Partially Sighted People collection (SSDA902).</p><p> </p><p>Notes:</p><p> </p><p>Data is also collected on registrations from those who are partially sighted/sight impaired. The figures in the table relate only to those registered blind or severely sight impaired.</p><p> </p><p>*Data is rounded to the nearest five.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 24/04/2018 14:10:37 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4131 label Biography information for Jim Shannon

890084

registered interest
date	23/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Perinatal Mortality
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many Health Service Investigation Branch investigations into late-term stillbirths were (a) undertaken and (b) completed in 2017.
tabling member constituency	Lewes
tabling member printed	Maria Caulfield
uin	137134
answer	answer is ministerial correction date of answer 01/05/2018 answer text <p>The Healthcare Safety Investigation Branch (HSIB) began work in April 2017 to conduct high-level investigations of serious patient safety incidents in the National Health Service in England with a specific focus on system-wide learning and improvement.</p><p> </p><p>In November 2017, my Rt. hon. Friend the Secretary of State announced that, from April 2018, HSIB would investigate all cases of early neonatal deaths, term intrapartum stillbirths and cases of severe brain injury in babies, as well as all cases of maternal death in England. HSIB did not conduct investigations in these areas in 2017.</p><p> </p><p>The new investigative approach will begin in a single region from April 2018 and rollout to all areas of England will be completed by the end of March 2019. It is estimated that there are approximately 1,000 cases of birth-related deaths or serious brain injuries in babies in England every year. The expectation is that the learning from investigations will spur system improvements leading to fewer deaths and injuries in the future.</p><p> </p><p>The Secretary of State has been clear that the HSIB maternity investigations will involve patients and families in investigations. In carrying out the maternity investigations, the HSIB will consult and seek evidence or information from the patient, family members and staff involved in the care. In addition, the HSIB will share draft reports with family members, inviting comment, and provide family members with the final report.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 137135 137136 question first answered 01/05/2018 10:14:31 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4492 label Biography information for Maria Caulfield

890085

registered interest
date	23/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Babies: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, on what date the Health Service Investigation Branch took responsibility for investigating avoidable baby deaths; and what estimate he has made of the annual caseload in each of the next three years.
tabling member constituency	Lewes
tabling member printed	Maria Caulfield
uin	137135
answer	answer is ministerial correction date of answer 01/05/2018 answer text <p>The Healthcare Safety Investigation Branch (HSIB) began work in April 2017 to conduct high-level investigations of serious patient safety incidents in the National Health Service in England with a specific focus on system-wide learning and improvement.</p><p> </p><p>In November 2017, my Rt. hon. Friend the Secretary of State announced that, from April 2018, HSIB would investigate all cases of early neonatal deaths, term intrapartum stillbirths and cases of severe brain injury in babies, as well as all cases of maternal death in England. HSIB did not conduct investigations in these areas in 2017.</p><p> </p><p>The new investigative approach will begin in a single region from April 2018 and rollout to all areas of England will be completed by the end of March 2019. It is estimated that there are approximately 1,000 cases of birth-related deaths or serious brain injuries in babies in England every year. The expectation is that the learning from investigations will spur system improvements leading to fewer deaths and injuries in the future.</p><p> </p><p>The Secretary of State has been clear that the HSIB maternity investigations will involve patients and families in investigations. In carrying out the maternity investigations, the HSIB will consult and seek evidence or information from the patient, family members and staff involved in the care. In addition, the HSIB will share draft reports with family members, inviting comment, and provide family members with the final report.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 137134 137136 question first answered 01/05/2018 10:14:31 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4492 label Biography information for Maria Caulfield

890086

registered interest
date	23/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Babies: Death
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether parents will be involved in Health Service Investigation Branch investigations of avoidable baby deaths; and whether evidence collected during such investigations will be shared with parents.
tabling member constituency	Lewes
tabling member printed	Maria Caulfield
uin	137136
answer	answer is ministerial correction date of answer 01/05/2018 answer text <p>The Healthcare Safety Investigation Branch (HSIB) began work in April 2017 to conduct high-level investigations of serious patient safety incidents in the National Health Service in England with a specific focus on system-wide learning and improvement.</p><p> </p><p>In November 2017, my Rt. hon. Friend the Secretary of State announced that, from April 2018, HSIB would investigate all cases of early neonatal deaths, term intrapartum stillbirths and cases of severe brain injury in babies, as well as all cases of maternal death in England. HSIB did not conduct investigations in these areas in 2017.</p><p> </p><p>The new investigative approach will begin in a single region from April 2018 and rollout to all areas of England will be completed by the end of March 2019. It is estimated that there are approximately 1,000 cases of birth-related deaths or serious brain injuries in babies in England every year. The expectation is that the learning from investigations will spur system improvements leading to fewer deaths and injuries in the future.</p><p> </p><p>The Secretary of State has been clear that the HSIB maternity investigations will involve patients and families in investigations. In carrying out the maternity investigations, the HSIB will consult and seek evidence or information from the patient, family members and staff involved in the care. In addition, the HSIB will share draft reports with family members, inviting comment, and provide family members with the final report.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 137134 137135 question first answered 01/05/2018 10:14:31 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4492 label Biography information for Maria Caulfield

890094

registered interest
date	23/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Department of Health and Social Care: Local Government
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many meetings he has had with representatives of local authorities since 1 January 2018.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	137144
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>The Secretary of State regularly meets a wide range of stakeholders to discuss a number of issues.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 26/04/2018 11:22:26 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1506 label Biography information for Andrew Gwynne

890118

registered interest
date	23/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Trials
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to maintain competition in clinical trials after the UK leaves the EU.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	137168
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>The Government has made clear that a key priority through the negotiations will be to ensure that the United Kingdom remains one of the best places in the world for science and innovation, including clinical trials. Every Government department, including the Department of Health and Social Care, is planning to deliver a smooth exit under any scenario, which includes preparing the UK for the future economic partnership we hope to negotiate with the European Union, as well as the very unlikely scenario in which no mutually satisfactory agreement can be reached and the UK exits without a deal.</p><p> </p><p>If the clinical trials regulation comes into force during the implementation period, as it is currently expected to do in March 2020, it will apply to the UK. The withdrawal agreement and implementation Bill will give effect to the implementation period in domestic law and will allow regulations to continue to apply in the UK for this time-limited period. If this opportunity does not come to pass, we will give priority to taking the steps necessary to bring into UK law, without delay, all relevant parts of the EU regulation that are within the UK’s control, so that those planning clinical research can do so with certainty.</p><p> </p><p>The UK is already a preferred destination for EU and global clinical trials. The Government has been clear that it is in the interest of patients and the life sciences industry across Europe for the UK and EU to find a way to continue cooperation in the field of clinical trials, and for continued sharing of data and information, even if our precise relationship with the EU will by necessity change. As part of the Department’s Exiting the EU programme, officials are working to ensure appropriate coordination across a number of projects relating to research and clinical trials including workforce, regulations, funding and rare diseases.</p><p> </p><p>The National Institute for Health Research (NIHR) provides the support, expertise and facilities that the National Health Service needs to undertake world-leading clinical trials funded by the NIHR, and other public, charity and life sciences industry partners, by funding a range of infrastructure facilities and the Clinical Research Network. Through NIHR and its partners, and by close collaboration with the life sciences sector and industry, the Government will ensure that the UK remains one of the best places in the world for research, science and innovation.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 26/04/2018 11:21:29 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4036 label Biography information for Luciana Berger

890119

registered interest
date	23/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Clinical Trials: EU Law
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to ensure continued access to the EU clinical trials portal and database after the UK leaves the EU.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	137169
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>If the Clinical Trials Regulation comes into force during the Implementation Period, as it is currently expected to in March 2020, it will apply to the United Kingdom. The Withdrawal Agreement and Implementation Bill will give effect to the implementation period in domestic law and will allow regulations to continue to apply in the UK for this time-limited period.</p><p> </p><p>If this opportunity does not come to pass, we will give priority to taking the steps necessary to bring into UK law, without delay, all relevant parts of the European Union regulation that are within the UK’s control, so that those planning clinical research can do so with certainty.</p><p> </p><p>The two key elements of the Regulation that are outside of the UK’s control, and this guarantee does not therefore cover, are the use of a shared central IT portal and database and participation in the single assessment model, both of which require a negotiated UK/EU agreement regarding UK involvement post-Brexit. We cannot pre-empt these negotiations, nor can we disadvantage the UK’s position in these negotiations by giving any further guarantees at this time.</p><p> </p><p>Regardless of the outcome of a Brexit deal and the application date of the Regulation, the UK is committed to offering a competitive service for clinical trial assessment. This covers regulatory approval from the Medicines and Health products Regulatory Agency (MHRA) as well as services from the Health Research Authority, ethics services, the National Institute for Health Research and the National Health Service. The current regulatory approval legislation will stay in place until such time as any changes are needed so there will be no interruption in UK clinical trials approval.</p><p> </p><p>In the event that the UK is not part of the EU shared central IT portal and database and therefore trials to be run wholly or in part in the UK are not submitted through the EU portal, it will still be perfectly possible for sponsors to run multistate trials involving the UK. Sponsors would have to apply to the MHRA as well as to the EU concerned states. However, MHRA would take every effort to ensure that a parallel submission to the MHRA was as streamlined and efficient as possible and that we were able to match or better the European timeline for assessment. MHRA and UK ethics committees are already internationally recognised for their robust yet timely assessment of trial applications and the UK is currently one of the most competitive Member States for timelines.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 26/04/2018 11:20:11 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4036 label Biography information for Luciana Berger

890120

registered interest
date	23/04/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans his Department has to support the maintenance of links between regulators, research ethics committees, researchers and the pharmaceutical industry in the UK and the European Medicines Agency after the UK leaves the EU.
tabling member constituency	Liverpool, Wavertree
tabling member printed	Luciana Berger
uin	137170
answer	answer is ministerial correction date of answer 26/04/2018 answer text <p>The Department has always made clear its intention to retain a close working partnership with the European Union, in the interest of ensuring patients continue to have timely access to safe medicines and medical innovations. This includes maintaining a strong working relationship with the European Medicines Agency on all aspects of the life sciences sector.</p><p> </p><p>It is of mutual benefit for the EU to collaborate closely with such a well-developed life sciences market in the United Kingdom. Both sides will always be stronger by working in partnership.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 26/04/2018 11:23:42 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	4036 label Biography information for Luciana Berger